Cerus
CERS
#7698
Rank
A$0.54 B
Marketcap
A$2.82
Share price
-9.66%
Change (1 day)
0.88%
Change (1 year)

Cerus (CERS) - Total debt

Total debt on the balance sheet as of September 2025 : A$0.14 Billion

According to Cerus's latest financial reports the company's total debt is A$0.14 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Cerus - Total debt on balance sheet (from 1997 to 2025)

Total debt by year

Year Total debt Change
2024-12-31A$0.15 B11.93%
2023-12-31A$0.14 B9.92%
2022-12-31A$0.12 B6.11%
2021-12-31A$0.12 B38.87%
2020-12-31A$86.99 M-5.5%
2019-12-31A$92.05 M117.1%
2018-12-31A$42.4 M11.09%
2017-12-31A$38.16 M42%
2016-12-31A$26.87 M-1.13%
2015-12-31A$27.18 M125.37%
2014-12-31A$12.06 M219.66%
2013-12-31A$3.77 M-49.23%
2012-12-31A$7.43 M5.61%
2011-12-31A$7.03 M46.07%
2010-12-31A$4.81 M17933.58%
2009-12-31A$0.02 M
2008-12-31N/A-100%
2007-12-31A$0.03 M-75.13%
2006-12-31A$0.14 M-97.83%
2005-12-31A$6.78 M-86.55%
2004-12-31A$50.39 M-32.93%
2003-12-31A$75.14 M82909.74%
2002-12-31A$0.09 M-43.66%
2001-12-31A$0.16 M-22.56%
2000-12-31A$0.2 M-6.62%
1999-12-31A$0.22 M
1997-12-31A$0.15 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Haemonetics
HAE
A$1.84 B 1,147.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
A$0.83 M-99.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Boston Scientific
BSX
A$18.17 B 12,168.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Utah Medical Products
UTMD
A$0.38 M-99.74%๐Ÿ‡บ๐Ÿ‡ธ USA